These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25063826)

  • 1. TwHF versus methotrexate in the treatment of rheumatoid arthritis: response to Landewe's comment on the TRIFRA study.
    Lv QW; Chen T; Zhang W; Shi Q; Zheng WJ; Lipsky PE; Zhang X
    Ann Rheum Dis; 2014 Oct; 73(10):e63. PubMed ID: 25063826
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: 'comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial' by Qian-wen et al.
    Landewé RB; van der Heijde D
    Ann Rheum Dis; 2014 Oct; 73(10):e62. PubMed ID: 25013090
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial.
    Lv QW; Zhang W; Shi Q; Zheng WJ; Li X; Chen H; Wu QJ; Jiang WL; Li HB; Gong L; Wei W; Liu H; Liu AJ; Jin HT; Wang JX; Liu XM; Li ZB; Liu B; Shen M; Wang Q; Wu XN; Liang D; Yin YF; Fei YY; Su JM; Zhao LD; Jiang Y; Li J; Tang FL; Zhang FC; Lipsky PE; Zhang X
    Ann Rheum Dis; 2015 Jun; 74(6):1078-86. PubMed ID: 24733191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TRIFRA trial: efforts employed to minimise expectation bias.
    Lv QW; Zhang W; Shi Q; Zheng WJ; Lipsky PE; Zhang X
    Ann Rheum Dis; 2014 Nov; 73(11):e67. PubMed ID: 25057182
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to D.M. Marcus's comment on the TRIFRA study (comparison of Tripterygium wilfordii Hook F vs methotrexate in the treatment of active rheumatoid arthritis).
    Lv QW; Zhang W; Shi Q; Zheng WJ; Lipsky PE; Zhang X
    Ann Rheum Dis; 2014 Sep; 73(9):e57. PubMed ID: 25085980
    [No Abstract]   [Full Text] [Related]  

  • 6. Paying attention to the preciseness of conclusion.
    Yuan K; Chen J; Li T; Xu A
    Ann Rheum Dis; 2014 Nov; 73(11):e66. PubMed ID: 25038235
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis.
    Wang X; Zu Y; Huang L; Yu J; Zhao H; Wen C; Chen Z; Xu Z
    Life Sci; 2017 Feb; 171():45-50. PubMed ID: 28088452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis.
    Wang HL; Jiang Q; Feng XH; Zhang HD; Ge L; Luo CG; Gong X; Li B
    BMC Complement Altern Med; 2016 Jul; 16():215. PubMed ID: 27411429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of rheumatoid arthritis.
    Marcus DM
    Ann Rheum Dis; 2014 Sep; 73(9):e56. PubMed ID: 24938284
    [No Abstract]   [Full Text] [Related]  

  • 10. 2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis.
    Zhang X; Xia J; Jiang Y; Pisetsky DS; Smolen JS; Mu R; Dai S; Weinblatt ME; Kvien TK; Li J; Dörner T; Zhang Y; Lu L; Yang C; Yang P; Zhang Y; Xu C; Zhao Z; Lipsky PE
    J Autoimmun; 2024 Jan; 142():103148. PubMed ID: 37967495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripterygium wilfordii Inhibiting Angiogenesis for Rheumatoid Arthritis Treatment.
    Zhang W; Li F; Gao W
    J Natl Med Assoc; 2017 Summer; 109(2):142-148. PubMed ID: 28599756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and effectiveness of a chloroform/methanol extract of Tripterygium wilfordii Hook F (T2) plus methotrexate in treating rheumatoid arthritis.
    Zhang W; Shi Q; Zhao LD; Li Y; Tang FL; Zhang FC; Zhang X
    J Clin Rheumatol; 2010 Dec; 16(8):375-8. PubMed ID: 21085018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of circulating miR-146a in patients with rheumatoid arthritis treated by Tripterygium wilfordii Hook F.
    Chen ZZ; Zhang XD; Chen Y; Wu YB
    Medicine (Baltimore); 2017 May; 96(20):e6775. PubMed ID: 28514293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs.
    Kim SC; Solomon DH; Liu J; Franklin JM; Glynn RJ; Schneeweiss S
    Am J Med; 2015 May; 128(5):539.e7-17. PubMed ID: 25534420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting and verifying outcome of Tripterygium wilfordii Hook F. based therapy in rheumatoid arthritis: from open to double-blinded randomized trial.
    Jiang M; Zha Q; Zhang C; Lu C; Yan X; Zhu W; Liu W; Tu S; Hou L; Wang C; Zhang W; Liang Q; Fan B; Yu J; Zhang W; Liu X; Yang J; He X; Li L; Niu X; Liu Y; Guo H; He B; Zhang G; Bian Z; Lu A
    Sci Rep; 2015 Apr; 5():9700. PubMed ID: 26814847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on: Methotrexate pharmacogenomics in rheumatoid arthritis: introducing false positive report probability.
    Beretta L
    Rheumatology (Oxford); 2009 Dec; 48(12):1619-20; author reply 1620. PubMed ID: 19828599
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach.
    Devine EB; Alfonso-Cristancho R; Sullivan SD
    Pharmacotherapy; 2011 Jan; 31(1):39-51. PubMed ID: 21182357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of folic acid supplementation on the efficacy of methotrexate treatment in rheumatoid arthritis: comment on the article by Khanna et al.
    Morgan SL; Baggott JE; Alarcón GS
    Arthritis Rheum; 2006 May; 54(5):1708-9; author reply 1709-10. PubMed ID: 16646062
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis.
    Castrejón I; Gibson KA; Pincus T
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S20-8. PubMed ID: 24219037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of golimumab combined with methotrexate on radiographic progression in rheumatoid arthritis: comment on the article by Emery et al.
    Graudal N; Jürgens G
    Arthritis Rheum; 2012 Apr; 64(4):1297-8; author reply 1298-9. PubMed ID: 22231914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.